In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci.
The in vitro activities of LY333328 were compared with those of vancomycin, teicoplanin, and quinupristin-dalfopristin (Synercid) against 219 strains of enterococci and staphylococci, including vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus. MICs and MBCs were deter...
Tallennettuna:
| Julkaisussa: | Antimicrob Agents Chemother |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology (ASM)
1996
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163545/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8891155/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.10.2416 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
